E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

Investor Relations

DGX (Common Stock)
ExchangeNYSE (US Dollar)
Price$66.34
Change (%) Stock is Up 0.78 (1.19%)
Intraday High$66.84
Intraday Low$65.51
Volume1,977,616
Data as of 12/19/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Headlines More >
TitleDate
FDA Clears the Focus Diagnostics Simplexa™ Flu A/B & RSV Direct Test to Include Eight Circulating Influenza Viruses
CYPRESS, Calif. and MADISON, N.J., Dec. 9, 2014 /PRNewswire/ -- As the 2014-2015 flu season begins, Focus Diagnostics, the products business of Quest Diagnostics (NYSE: DGX), today announced that its Simplexa™ Flu A/B & RSV Direct Kit has received FDA clearance for eight additional influenza strains. These strains may pose significant potential health risks and may be circulating this winter. The FDA, which granted 510(k) clearance to the test kit originally in July 2012, cleared additional ... 
12/09/14
Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Dec. 4, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.33 per share, payable on January 28, 2015 to shareholders of record of Quest Diagnostics common stock on January 13, 2015. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic information services that patients and doctors need to ma... 
12/04/14
Quest Diagnostics To Speak At The Piper Jaffray 26th Annual Healthcare Conference
MADISON, N.J., Dec. 1, 2014 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Piper Jaffray 26th Annual Healthcare Conference in New York City.  Mark Guinan, the company's Senior Vice President and CFO, will discuss the company's vision, goals and five point strategy.  The presentation is scheduled for Tuesday, December 2, 2014 at 9:30 a.m. Eastern Time. The presentation... 
12/01/14
Quest Diagnostics Discusses Progress in Executing Strategy to Drive Shareholder Value and Presents Outlook at Investor Day
- Company Expects to Generate 2% to 5% Revenue Growth and Adjusted Diluted EPS Growth of 8% to 10% on Average Over Next Three Years - - New Target of $600 Million in Additional Run-Rate Savings Over Next Three Years Will Bring Total Run-Rate Savings Expected by End of 2017 to $1.3 billion - NEW YORK, Nov. 5, 2014 /PRNewswire/ -- At a meeting with analysts and investors at its Investor Day here today, members of the senior management team of Quest Diagnostics Incorporated (NYSE: DGX), the... 
11/05/14
Upcoming EventsMore >
DateTitle
01/06/15
Quest Diagnostics at Goldman Sachs Healthcare CEOs Unscripted Conference
01/14/15
Quest Diagnostics at JPMorgan Healthcare Conference
01/29/15
Q4 2014 Quest Diagnostics Earnings Conference Call
Contact Us:
Dan Haemmerle
Executive Director Investor Relations
973-520-2900
Investor@QuestDiagnostics.com

Company Calendar
December 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-1123
12/03/14
4
Formats:  HTML Adobe PDF Word
456
78910111213
14151617
12/17/14
4
Formats:  HTML Adobe PDF Word
181920
21222324252627
28293031515253

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.